Evidence map›Paper›PMID 37344722›Full record

Observational studyJournal of endocrinological investigation2024

Paradoxical GH increase after oral glucose load in subjects with and without acromegaly.

F Ceccato, C K Vedolin, G Voltan, G Antonelli, M Barbot, D Basso, D Regazzo, C Scaroni, G Occhi

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Journal of endocrinological investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. [Abnormal elevation of growth hormone in patients with pituitary adenoma combined with cirrhosis: A case report].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

F CeccatoDepartment of Medicine DIMED, University of Padova, Padua, Italy.
C K VedolinDepartment of Medicine DIMED, University of Padova, Padua, Italy.
G VoltanDepartment of Medicine DIMED, University of Padova, Padua, Italy.
G AntonelliDepartment of Medicine DIMED, University of Padova, Padua, Italy.
M BarbotDepartment of Medicine DIMED, University of Padova, Padua, Italy.
D BassoDepartment of Medicine DIMED, University of Padova, Padua, Italy.
D RegazzoDepartment of Medicine DIMED, University of Padova, Padua, Italy.
C ScaroniDepartment of Medicine DIMED, University of Padova, Padua, Italy.
G OcchiDepartment of Biology, University of Padova, Via Via U. Bassi 58B, 35121, Padua, Italy. gianluca.occhi@unipd.it.ORCID http://orcid.org/0000-0003-4065-4677
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveA paradoxical GH rise after the glucose load (GH-Par) is described in about one-third of acromegalic patients. Here, we evaluated the GH profile in subjects with and without acromegaly aiming to refine the definition of GH-Par.

designObservational case-control study.

methodsOur cohort consisted of 60 acromegalic patients, and two groups of subjects presenting suppressed GH (< 0.4 µg/L) and high (non-acro

resultsA similar proportion of subjects in all three groups shows a GH ratio of ≥ 120% starting from 120 min. Re-considering the definition of paradoxical increase of GH within 90 min, we observed that the prevalence of GH peaks ≥ 120% was higher in acromegaly than in non-acro

conclusionsGH-Par response may be defined as a 20% increase in the first 90 min after glucose challenge. GH-Par, common in acromegaly and associated with an increased prevalence of glucose metabolism abnormalities, is found also in a subset of non-acromegalic subjects with high IGF-1 levels, suggesting its possible involvement in the early phase of the disease.

Indexed as

AcromegalyHuman Growth HormoneCase-Control StudiesGlucoseHumansInsulin-Like Growth Factor IGlucoseHuman Growth HormoneInsulin-Like Growth Factor IAcromegaly, IGF-1GIPOral glucose tolerance testParadoxical response

Identifiers

PMID37344722
PMCPMC10776735
OpenAlexW4381550068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.